Substituted hydantoins

Details for Australian Patent Application No. 2005274390 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Kong, Norman; Moliterni, John Anthony; Huby, Nicholas John Silvester; Chu, Xin-Jie; Zhang, Zhuming; McDermott, Lee Apostle; Fotouhi, Nader

Agent Davies Collison Cave

Pub. Number AU-B-2005274390

PCT Pub. Number WO2006/018188

Priority 60/682,997 20.05.05 US; 60/602,175 17.08.04 US

Filing date 9 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 19 January 2012

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018188 Priority application(s): WO2006/018188

19 January 2012 Application Accepted

  Published as AU-B-2005274390

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005274399-Process for identification of compounds for modulating the activity of a sodium/ calcium exchange transporter

2005274387-Dihydropteridinones for the treatment of cancer diseases